CAIAZZO, GIUSEPPINA
 Distribuzione geografica
Continente #
AS - Asia 1.826
NA - Nord America 1.451
EU - Europa 1.211
SA - Sud America 243
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 4.794
Nazione #
US - Stati Uniti d'America 1.387
SG - Singapore 799
RU - Federazione Russa 582
CN - Cina 373
VN - Vietnam 348
IT - Italia 217
BR - Brasile 199
HK - Hong Kong 113
DE - Germania 82
FR - Francia 64
FI - Finlandia 55
GB - Regno Unito 47
IN - India 46
IE - Irlanda 41
CA - Canada 40
NL - Olanda 37
KR - Corea 26
CI - Costa d'Avorio 25
JP - Giappone 24
UA - Ucraina 22
PL - Polonia 19
AR - Argentina 18
BD - Bangladesh 17
MX - Messico 14
TH - Thailandia 11
TR - Turchia 11
ZA - Sudafrica 11
PH - Filippine 9
EC - Ecuador 8
ES - Italia 8
IQ - Iraq 8
SE - Svezia 8
PK - Pakistan 6
PY - Paraguay 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
RO - Romania 4
SN - Senegal 4
TW - Taiwan 4
CL - Cile 3
DK - Danimarca 3
ID - Indonesia 3
JM - Giamaica 3
LT - Lituania 3
TN - Tunisia 3
UZ - Uzbekistan 3
AT - Austria 2
AZ - Azerbaigian 2
DZ - Algeria 2
EG - Egitto 2
GA - Gabon 2
IR - Iran 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
MA - Marocco 2
NP - Nepal 2
RS - Serbia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AI - Anguilla 1
AM - Armenia 1
AS - Samoa Americane 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CM - Camerun 1
CO - Colombia 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HR - Croazia 1
IL - Israele 1
LU - Lussemburgo 1
ME - Montenegro 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
ZM - Zambia 1
Totale 4.794
Città #
Singapore 403
San Jose 233
Moscow 136
Chandler 134
Ashburn 130
Beijing 114
Hong Kong 110
Ho Chi Minh City 88
Hanoi 85
Hefei 75
Santa Clara 65
Napoli 47
Naples 45
Lauterbourg 40
Los Angeles 40
The Dalles 38
Millbury 31
Amsterdam 28
Helsinki 26
Des Moines 24
Buffalo 22
Boston 21
Frankfurt am Main 20
Tokyo 18
Nanjing 17
Princeton 17
Dallas 16
New York 16
Redondo Beach 15
Turku 15
Da Nang 14
Dong Ket 14
Lawrence 13
Munich 13
Orem 13
Seoul 13
Warsaw 13
Haiphong 12
Ottawa 12
Rome 12
São Paulo 12
Chennai 11
Chicago 11
Council Bluffs 11
Jacksonville 11
Seattle 10
Boardman 9
Dublin 9
Falkenstein 9
Rio de Janeiro 9
Arezzo 8
Denver 8
Kochi 8
London 8
Toronto 8
Houston 7
Milan 7
Montreal 7
Brooklyn 6
Guarulhos 6
Hải Dương 6
Mexico City 6
Nanchang 6
Shenyang 6
Trecase 6
Wilmington 6
Woodbridge 6
Abidjan 5
Atlanta 5
Catania 5
Curitiba 5
Düsseldorf 5
Guangzhou 5
Jiaxing 5
Poplar 5
Shenzhen 5
Tân Tiến 5
Baghdad 4
Biên Hòa 4
Dakar 4
Guayaquil 4
Lappeenranta 4
Miami 4
Norwalk 4
Nuremberg 4
Phoenix 4
Pune 4
Quận Bình Thạnh 4
San Francisco 4
Shanghai 4
Stockholm 4
Thái Nguyên 4
Washington 4
Asunción 3
Brasília 3
Bucharest 3
Can Tho 3
Caxias do Sul 3
Changsha 3
Erbil 3
Totale 2.550
Nome #
Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage 186
Anti-TNF-α therapy modulates mTORC1 signalling in hidradenitis suppurativa 175
Exploring Anti-Fungal, Anti-Microbial and Anti-Inflammatory Properties of a Topical Non-Steroidal Barrier Cream in Face and Chest Seborrheic Dermatitis 162
IL-26 in allergic contact dermatitis: resource in a state of readiness 157
Possible role of BMP-4 in the hyper-pigmentation of psoriatic plaques after anti-TNF-α treatment 150
Use of Natural Agents and Agrifood Wastes for the Treatment of Skin Photoaging 145
Azeloglycine and nicotinamide down-regulate pro-inflammatory mediators in vitro 140
A new T helper 17 cytokine in hidradenitis suppurativa: antimicrobial and proinflammatory role of interleukin-26 138
Immunologic skin signatures in SARS-CoV-2-negative patients with chilblain-like lesions. 137
Eczematous drug eruption in patients with psoriasis under anti‐interleukin‐17A: does interleukin‐22 play a key role? 132
Mammalian target of rapamycin is increased in hidradenitis suppurativa and acne being related to insulin resistance 131
Psoriasis, cardiovascular events, and biologics: Lights and shadows 128
Antiflammatory activity and potential dermatological applications of characterized humic acids from a lignite and a green compost 123
IL-36γ Is Involved in Psoriasis and Allergic Contact Dermatitis 123
Irisin, a novel metabolic biomarker in hidradenitis suppurativa: correlation with clinical responsivity to anti-TNF-α therapy 122
Chronic hand Eczema: Is IL-36á helpful in diagnosis and classification? 122
Biologics that inhibit the Th17 pathway and related cytokines to treat inflammatory disorders 120
Safety concerns with current treatments for psoriasis in the elderly 120
Beneficial effects of Rocchetta® oligomineral water in HaCaT keratinocytes after ultraviolet-B irradiation 119
Effectiveness of Brodalumab in Patients with Moderate-to-Severe Plaque Psoriasis Located in Difficult-to-Treat Areas 116
Desmosomes in heart and skin: friends or foes? 115
Increased expression of interleukin-23A in lesional skin of patients with atopic dermatitis with psoriasiform reaction during dupilumab treatment 115
The Use of JAK/STAT Inhibitors in Chronic Inflammatory Disorders 114
Mechanistic target of rapamycin complex 1 is involved in psoriasis and regulated by anti-TNF-α treatment 113
The increase of mTOR expression is consistent with FoxO1 decrease at gene level in acne but not in psoriasis 113
IL-36 cytokines are increased in acne and hidradenitis suppurativa 109
Psoriatic arthritis onset in psoriatic patients receiving UV phototherapy in Italy 106
Very low-calorie ketogenic diet (VLCKD) in the management of hidradenitis suppurativa (Acne Inversa): an effective and safe tool for improvement of the clinical severity of disease. Results of a pilot study 104
Mesenchymal stem cells participate to inflammatory skin process of atopic dermatitis 102
The anti-drug antibodies detection: a valuable tool for clinical response loss in psoriatic patients? 102
Response to: 'Interleukin-36 in hidradenitis suppurativa: Evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop' 101
Reply to "Psoriasis exacerbation after Covid-19 vaccination: report of 14 cases from a single center" by Sotiriou E et al 92
Polymorphic light eruption and IL-1 family members: any difference with allergic contact dermatitis? 91
Author reply to: Comment on: 'Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?' 90
Mammalian target of rapamycin, insulin resistance and hidradenitis suppurativa: A possible metabolic loop 89
Paraoxonases and psoriasis: negative imbalance of anti--oxidant endogenous mechanisms 89
Anti IL-17 therapy rapidly decreases osteoclast activity in psoriatic patients: a novel quality in addition to its efficacy and safety 88
Mechanistic target of rapamycin (mTOR) expression is increased in acne patients' skin. 87
The effects of etanercept on replication, proliferation, survival, and apoptosis markers in moderate to severe psoriasis. 83
Small fragments sodium sulfated hyaluronate, more than hyaluronic acid, reduces LPS-induced cytokine/chemokine levels in HaCaT cells 81
Very low-calorie ketogenic diet (VLCKD): a therapeutic nutritional tool for acne? 79
The effect of tildrakizumab on adipokines production in patients affected by psoriasis and obesity: preliminary results from a single center real-life study 61
Phenotype-endotype relationship in elderly atopic dermatitis and effects of dupilumab therapy: prospective study 30
Totale 4.900
Categoria #
all - tutte 15.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.277


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 0 14
2021/2022201 1 0 6 1 6 17 1 4 25 17 50 73
2022/2023317 32 35 9 23 37 29 2 27 57 24 27 15
2023/2024282 12 36 17 35 20 29 4 45 9 17 39 19
2024/20251.337 59 62 22 21 46 82 132 108 85 149 479 92
2025/20262.410 228 200 263 233 419 99 262 139 318 170 60 19
Totale 4.900